Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-Label Study Assessing Dyad (Subject And Caregiver) Perception Of Convenience And Preference Of The Newly Developed Mark VII Injection Pen

NCT00965484 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00965484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-Label Study Assessing Dyad (Subject And Caregiver) Perception Of Convenience And Preference Of The Newly Developed Mark VII Injection Pen
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2010
Enrollment
136 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency, idiopathic short stature